- Develop a model for sustainable supply and costing
- Model the impact of different use cases and scenarios
- Pilot antihelmintic resistance surveillance based on genetic epidemiology
- ## Basic facts del proyecto
- En qué call de EDCTP (Global Health EDCTP3) ha salido
- Project duration (36 months); cuando empieza y cuando acaba (20 junio 2026)
-
- ## Timeline y milestones (cuáles se han cumplido?)
- __Proposed safety and effectiveness study__
- *Primary objective*: To evaluate and compare safety of a [[FDC]] against [[Albendazole]] alone via [[MDA]] in two study areas in Kenya and [[Ghana]].
@ -46,9 +50,6 @@
- The access plan is being developed
- Integration across programs (these results have implications beyond STH)
- Progress has been achieved through public-private partnerships but more partners are needed to reach the ultimate goal.
- Project duration (36 months); cuando empieza y cuando acaba (20 junio 2026)
- ## Basic facts del proyecto
-
- ## Investigadores principales de cada uno de los partners
- ## Abstract del proyecto
- [[Soil-Transmitted Helminths]] (STH) remain a significant public health problem with recognized obstacles for control and elimination with the current benzimidazole regimens in [[Mass Drug Administration]] (MDA) campaigns. Renewed targets from [[WHO]] for 2030 include elimination of [[STH]] morbidity in pre-school and school age children (PSAC & SAC), increased country governance and financial support and a strongyloidiasis control program; 2030 has also been targeted by [[WHO]] for controlling NTDs to attain the Sustainable Development Goals.
Borja Robert
11 months ago